Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran

被引:51
作者
Sepehr, A
Tanière, P
Martel-Planche, G
Zia'ee, AA
Rastgar-Jazii, F
Yazdanbod, M
Etemad-Moghadam, G
Kamangar, F
Saidi, F
Hainaut, P
机构
[1] IARC, Grp Mol Carcinogenesis, F-69008 Lyon, France
[2] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
[3] NRCGEB, Tehran, Iran
[4] Univ Tehran Med Sci, Dept Surg, Tehran, Iran
[5] Iran Mehr Hosp, Dept Pathol, Tehran, Iran
[6] Iran Mehr Hosp, Dept Surg, Tehran, Iran
[7] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
关键词
esophagus; neoplasms; Iran; p53; COX-2;
D O I
10.1038/sj.onc.1204912
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extremely high rates of squamous cell carcinoma of the esophagus (SCCE), are observed in Iran,, reflecting unknown, genetic and/or epidemiological risk factors. Among genetic alterations, in SCCE,: TP53: mutations are the most frequent, vary among populations, and may provide clues on etiological mechanisms. We have analysed mutations in TP53 (exons 5-8): in 98 SCCE from Iran by temporal temperature get electrophoresis and direct sequencing. We found 58, mutations, in 49 patients, (50%,), with a high prevalence of C to T transitions at CpG dinucleotides (29.3%). The TP53 mutation pattern in Iran was significantly different from that observed in SCCEs from high incidence areas of China and Western Europe (P=0.007)., Moreover, the prevalence of mutations at A:T base pairs, (transitions and transversions) was higher in men than in women (38.7%, vs 11.1%, P=0.033). COX-2 overexpression was, detected in 69% of the cases evaluated (24/35), without significant association with TP53, mutation. Accumulation of nitrotyrosine, a marker of protein damage by excess, levels of nitric oxide, was observed in tumor cells, in six of 16 cases analysed. These results are consistent with the hypothesis that several factors are involved in TP53 mutagenesis, in Iran., These factors include a baseline of chronic inflammatory stress, which may have a multiplicative impact on the sensitivity of esophageal cells to exogenous factors of risk.
引用
收藏
页码:7368 / 7374
页数:7
相关论文
共 50 条
  • [41] Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status
    Zhu, Xiaoqin
    Jamshed, Sarah
    Zou, Jian
    Azar, Azniv
    Meng, Xiuling
    Bathini, Venu
    Dresser, Karen
    Strock, Cara
    Yalamarti, Bhargavi
    Yang, Michelle
    Tomaszewicz, Keith
    Tjionas, George
    Mochel, Mark C.
    Hutchinson, Lloyd
    Bledsoe, Jacob R.
    MODERN PATHOLOGY, 2021, 34 (05) : 1017 - 1030
  • [42] HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
    Meulendijks, D. M
    Tomasoa, N. B.
    Dewit, L.
    Smits, P. H. M.
    Bakker, R.
    van Velthuysen, M-L F.
    Rosenberg, E. H.
    Beijnen, J. H.
    Schellens, J. H. M.
    Cats, A.
    BRITISH JOURNAL OF CANCER, 2015, 112 (08) : 1358 - 1366
  • [43] CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin
    Kusters-Vandevelde, Heidi V. N.
    Van Leeuwen, Arjanne
    Verdijk, Marian A. J.
    de Koning, Maurits N. C.
    Quint, Wim G. V.
    Melchers, Willem J. G.
    Ligtenberg, Marjolijn J. L.
    Blokx, Willeke A. M.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (09) : 2123 - 2132
  • [44] p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
    Sung, You-Na
    Kim, Deokhoon
    Kim, Jihun
    DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
  • [45] TP53 mutation in ovarian carcinoma
    Murphy, M
    McManus, DT
    Toner, PG
    Russell, SEH
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1281 - 1283
  • [46] LAMP3 and TP53 overexpression predicts poor outcome in laryngeal squamous cell carcinoma
    Qiu, Xiaoxia
    You, Yiwen
    Huang, Jianfei
    Wang, Xudong
    Zhu, Huijun
    Wang, Zhiwei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 5519 - 5527
  • [47] TP53 and gastric carcinoma: A review
    Fenoglio-Preiser, CM
    Wang, J
    Stemmermann, GN
    Noffsinger, A
    HUMAN MUTATION, 2003, 21 (03) : 258 - 270
  • [48] OROPHARYNGEAL SQUAMOUS CELL CARCINOMA TREATED WITH RADIOTHERAPY OR RADIOCHEMOTHERAPY: PROGNOSTIC ROLE OF TP53 AND HPV STATUS
    Fallai, Carlo
    Perrone, Federica
    Licitra, Lisa
    Pilotti, Silvana
    Locati, Laura
    Bossi, Paolo
    Orlandi, Ester
    Palazzi, Mauro
    Olmi, Patrizia
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (04): : 1053 - 1059
  • [49] Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation
    Amatya, VJ
    Takeshima, Y
    Kaneko, M
    Inai, K
    PATHOLOGY INTERNATIONAL, 2004, 54 (10) : 803 - 809
  • [50] A correlation of immunohistochemical expression of TP53 and severity of inflammation with varying grades of oral squamous cell carcinoma
    Pandya, Jay Ashokkumar
    Natarajan, Srikant
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (03) : 564 - 570